NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the IRA ICR Forms
Putting Patients First Blog
SEPTEMBER 3, 2024
We recommend that CMS offer more specific sub-questions, similar to other questions in the document, aimed at prioritizing the identification of health disparities that may affect access to and outcomes from the selected drug. 2022 AMA prior authorization (PA) physician survey. and Keating, N. Journal of Clinical Oncology, 42(8).
Let's personalize your content